Litigation
Jazz Pharmaceuticals, Inc. v. Amneal Pharmaceuticals, LLC et al.
settled2:13-cv-00391
Auto-generating section 1 of 5: Case overview & background…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
- Court
- D.N.J.
- Filed
- 2013-01-18
Patents at issue (1)
Plaintiffs (1)
Defendants (2)
Summary
Jazz asserted seven Xyrem patents, including the '275 patent; Amneal's answer included Count VII: Infringement of the '275 Patent. Consolidated into the D.N.J. Xyrem ANDA proceedings and ultimately resolved by settlement.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
In the news
What the press has reported about this case, summarized with links to the source articles.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).